SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-127710
Filing Date
2022-04-28
Accepted
2022-04-28 16:33:04
Documents
8
Period of Report
2022-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A d107411ddef14a.htm DEF 14A 304778
2 GRAPHIC g107411g00i44.jpg GRAPHIC 374602
3 GRAPHIC g107411g02o03.jpg GRAPHIC 44831
4 GRAPHIC g107411g13e02.jpg GRAPHIC 55069
5 GRAPHIC g107411g43b02.jpg GRAPHIC 51251
6 GRAPHIC g107411g53o41.jpg GRAPHIC 33431
7 GRAPHIC g107411g58k61.jpg GRAPHIC 49035
8 GRAPHIC g107411g77k76.jpg GRAPHIC 206855
  Complete submission text file 0001193125-22-127710.txt   1418761
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40881 | Film No.: 22867239
SIC: 2834 Pharmaceutical Preparations